Showing results (61-70 of 91) with videos related to

Sort By:
Pageof 10
Brain & Development|August 27, 2023
Survey of medications for myelomeningocele patients over their lifetime in JapanHaruna Isozaki, Masahiro Nonaka, Yumiko Komori, et al.
Journal of Neuroendovascular Therapy|July 28, 2023
Stent-Assisted Coil Embolization of Ruptured Blood Blister-Like Aneurysm of the Basilar Artery: A Case Report and Literature ReviewNatsumi Yamamura, Ryoichi Iwata, Takehiro Suyama, et al.
Journal of Neurosurgery. Pediatrics|October 4, 2011
Prenatal molecular diagnosis of a severe type of L1 syndrome (X-linked hydrocephalus)Mami Yamasaki, Masahiro Nonaka, Nobuhiro Suzumori, et al.
Molecular Carcinogenesis|November 8, 2024
MicroRNA-505-5p/-3p Regulates the Proliferation, Invasion, Apoptosis, and Temozolomide Resistance in Mesenchymal Glioma Stem Cells by Targeting AUF1Souichi Oe, Rio Kakizaki, Sumika Sakamoto, et al.
Neuro-Oncology|October 22, 2019
ICOSLG-mediated regulatory T-cell expansion and IL-10 production promote progression of glioblastomaRyoichi Iwata, Joo Hyoung Lee, Mikio Hayashi, et al.
BMC Cancer|September 16, 2021
Infrequent RAS mutation is not associated with specific histological phenotype in gliomasYasuhide Makino, Yoshiki Arakawa, Ema Yoshioka, et al.
Brain Tumor Pathology|May 4, 2020
Molecular characteristics and clinical outcomes of elderly patients with IDH-wildtype glioblastomas: comparative study of older and younger cases in Kansai Network cohortJunya Fukai, Hideyuki Arita, Toru Umehara, et al.
Anticancer Research|July 3, 2017
Systemic Intravenous Adoptive Transfer of Autologous Lymphokine-activated αβ T-Cells Improves Temozolomide-induced Lymphopenia in Patients with GliomaYonehiro Kanemura, Miho Sumida, Yoshiko Okita, et al.
Acta Neuropathologica Communications|June 20, 2019
Distribution differences in prognostic copy number alteration profiles in IDH-wild-type glioblastoma cause survival discrepancies across cohortsToru Umehara, Hideyuki Arita, Ema Yoshioka, et al.
Neuro-Oncology Advances|February 27, 2024
Prediction of MGMT promotor methylation status in glioblastoma by contrast-enhanced T1-weighted intensity imageTakahiro Sanada, Manabu Kinoshita, Takahiro Sasaki, et al.
Pageof 10